Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Drug Testing and Analysis|June 3, 2015
Isolation and characterization of a newly identified impurity in methamphetamine synthesized via reductive amination of 1-phenyl-2-propanone (P2P) made from phenylacetic acid/lead (II) acetateSteven G Toske, Jennifer B McConnell, Jaclyn L Brown, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 25, 2019
KRAS Binders Hidden in NatureAndreas Bergner, Xiaoling Cockcroft, Gerhard Fischer, et al.Chemical Communications (Cambridge, England)|December 2, 2024
Borates <i>vs</i>. aluminates: comparing the anion for lithium-ion batteriesDarren M C Ould, Megan E Penrod, Jessica B McConnell, et al.Journal of the American Chemical Society|January 27, 2025
Molecular Processes That Control Organic Electrosynthesis in Near-Electrode MicroenvironmentsRicardo Mathison, Rasha Atwi, Hannah B McConnell, et al.ACS Medicinal Chemistry Letters|June 6, 2014
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human RhinovirusSusanne C Feil, Stephanie Hamilton, Guy Y Krippner, et al.Chemmedchem|November 21, 2018
Targeted Synthesis of Complex Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2-p53 InhibitorsAndreas Gollner, Harald Weinstabl, Julian E Fuchs, et al.ACS Photonics|August 26, 2024
Microlens Hollow-Core Fiber Probes for Operando Raman SpectroscopyMegan J Groom, Ermanno Miele, Jonathan Pinnell, et al.Journal of Medicinal Chemistry|July 15, 2024
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical AssaysThomas Gerstberger, Helmut Berger, Frank H Büttner, et al.Journal of Medicinal Chemistry|July 11, 2003
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirusKeith G Watson, Renee N Brown, Rachel Cameron, et al.Molecular Cancer Therapeutics|September 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose SchedulesAndreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky, et al.Pageof 19